Trademark Overview
On Wednesday, June 18, 2025, a trademark application was filed for EKTERLY with the United States Patent and Trademark Office. The USPTO has given the EKTERLY trademark a serial number of 79429992. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 14, 2025. This trademark is owned by Kalvista Pharmaceuticals Limited. The EKTERLY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; pharmaceutical preparations containing sebetralstat for the treatment of angioedema, hereditary angioedema, bradykinin mediated inflammatory disorders, plasma kallikrein or factor XIIa mediated diseases or disorders, or diseases and disorders mediated by the contact activation system
